Author

C. W. Seidler

Observed names: C. Seidler, Christopher Seidler, Christopher W. Seidler

Institution: University of Massachusetts Chan Medical School

Observed institutions: Dartmouth–Hitchcock Medical Center, Mayo Clinic, Roger Williams Medical Center, University of Massachusetts Chan Medical School, University of Pittsburgh, Miriam Hospital, Saint Vincent Hospital, Utah Cancer Specialists, Magee-Womens Hospital, Highlands Oncology Group, UPMC Hillman Cancer Center, Mayo Clinic in Florida, UMass Memorial Medical Center, Dartmouth Cancer Center

OpenAlex ID: A5071494954

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

2006 · Adam Brufsky, W. Graydon Harker, et al. · Journal of Clinical Oncology · 322

Final 5‐year results of Z‐FAST trial

2011 · Adam M. Brufsky, W. Graydon Harker, et al. · Cancer · 193

Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial

2005 · A. Brufsky, W. G. Harker, et al. · Journal of Clinical Oncology · 54

Spontaneous factor VIII inhibitor occurring in association with chronic graft‐versus‐host disease

1994 · Christopher W. Seidler, Letha E. Mills, et al. · American Journal of Hematology · 19

Blood and Resource Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA) in the Pre- and Post-National Coverage Determination (NCD) Timeframes: Results From An Electronic Medical Record Study.

2009 · Tanya Burton, Luke Boulanger, et al. · Blood · 3

Gemcitabine and capecitabine in metastatic breast cancer (MBC): A Brown University Oncology Group (BrUOG) phase II study

2005 · W. M. Sikov, K. P. Theall, et al. · Journal of Clinical Oncology · 3

Phase I-II trial of daily thalidomide in combination with docetaxel in patients with relapsed non-small cell lung cancer: A final analysis

2006 · C. W. Seidler, E. Scepansky, et al. · Journal of Clinical Oncology · 2

Hematologic Recovery After Liver Transplantation

2013 · Christopher Seidler, Adel Bozorgzadeh, et al. · Blood

False negative rates of PET scanning in bronchoalveolar lung (BAL) cancer and its implication for diagnosis and staging

2007 · C. W. Seidler, A. Buttar, et al. · Journal of Clinical Oncology

P143 Combination of erythropoietin and low-dose thalidomide for the management of anemia of low-grade myelodysplasia

2007 · L. Leb, S. Khanani, et al. · Leukemia Research

Tumor-specific response rates to erythropoietin in chemotherapy-induced anemia in a community practice setting

2006 · S. Vasu, C. Seidler, et al. · Journal of Clinical Oncology

A retrospective pilot study of serum lipid levels and the risk of breast cancer

2006 · R. V. Raghupathy, C. W. Seidler, et al. · Journal of Clinical Oncology

A review of carboplatin and gemcitabine with sequential radiation therapy in the treatment of stage III and IV non-small cell lung cancer in the community setting

2005 · C. W. Seidler, D. Kodali, et al. · Journal of Clinical Oncology

Phase I/II trial of weekly docetaxel and carboplatin in previously untreated patients with advanced non-small cell lung cancer

2004 · W. Walsh, J. Gordon, et al. · Journal of Clinical Oncology

A phase I-II trial of docetaxel and daily thalidomide in patients with previously treated recurrent non-small cell lung cancer

2004 · C. W. Seidler, J. Rooney, et al. · Journal of Clinical Oncology

Works count: 15

Citation count: 596

H-index: 4

I10-index: 4